Universal reference book for medicines
Product name: CODELAC В® BRONCHO (CODELAC В® BRONCHO)

Active substance: comb.
drug
Type: The drug with mucolytic, expectorant and anti-inflammatory action

Manufacturer: Otisifarm (Russia) manufactured by FARMSTANDART-Lekssredstva (Russia)
Composition, form of production and packaging
?
Tablets from light cream to cream with a yellowish tinge color with darker and lighter blotches, flat-cylindrical, with a risk and a facet.
1 tab.

Ambroxol hydrochloride 20 mg

sodium glycyrrhizinate 30 mg

dry extract of thermopsis 10 mg

sodium hydrogen carbonate 200 mg

Auxiliary substances: potato starch, microcrystalline cellulose, povidone K25 (kollidone K25), talc, stearic acid, sodium carboxymethyl starch (sodium starch glycolate, primogel).

10 pieces.
- packings of cellular contour (1) - packs cardboard.
10 pieces.
- packings cellular planimetric (2) - packs cardboard.
INSTRUCTION FOR THE SPECIALIST.

Description of the drug approved by the manufacturer for the printed edition of 2010.

PHARMACHOLOGIC EFFECT

Combined drug for treating cough, has mucolytic and expectorant effect, and also has anti-inflammatory activity.
The action of CodelacВ® Broncho is due to the pharmacological properties of its components.
Ambroxol has secretory, secretory and expectorant action, normalizes the disturbed ratio of serous and mucous components of sputum, increases the secretion of surfactant in the alveoli.
Reduces the viscosity of sputum and promotes its spillage.
Glycyrrhate (glycyrrhizic acid and its salts) has anti-inflammatory and antiviral effects.
Has a cytoprotective effect due to antioxidant and membrane-stabilizing activity. Potentiates the action of endogenous GCS, providing anti-inflammatory and anti-allergic action. Due to its pronounced anti-inflammatory activity, it helps to reduce the inflammatory process in the respiratory tract.
Extract of thermopsis has an expectorant effect, having a moderate irritant effect on the receptors of the gastric mucosa, reflexively increases the secretion of the bronchial glands.

Sodium bicarbonate shifts the pH of bronchial mucus to the alkaline side, reduces the viscosity of sputum, stimulates the motor function of the ciliated epithelium and bronchioles.

PHARMACOKINETICS

Data on the pharmacokinetics of the drug KodelakВ® Broncho are not available.

INDICATIONS

Diseases of the respiratory tract with difficulty of sputum discharge:

- Acute and chronic bronchitis;

- pneumonia;

- COPD;

bronchoectatic disease.

DOSING MODE

The drug should be taken orally during meals.

Adults and children over 12 years of age are prescribed 1 tablet 3 times / day.

It is not recommended to use the drug for more than 4-5 days without prescribing a doctor.

SIDE EFFECT

From the side of the central nervous system: rarely - weakness, headache.

From the digestive system: rarely - diarrhea, dry mouth, constipation;
with prolonged use in high doses - gastralgia, nausea, vomiting.
From the respiratory system: rarely - dryness of the mucous membrane of the respiratory tract, rhinorrhea.

Other: rarely - dysuria, exanthema, allergic reactions.

CONTRAINDICATIONS

- Pregnancy;

- lactation period;

- children's age till 12 years;

- Hypersensitivity to the components of the drug.

With caution should be used in patients with hepatic and / or renal insufficiency, peptic ulcer of the stomach and duodenum, with bronchial asthma.

PREGNANCY AND LACTATION

The drug Kodelak В® Broncho is contraindicated in pregnancy and lactation (breastfeeding).

APPLICATION FOR FUNCTIONS OF THE LIVER

Caution should be used in patients with hepatic and / or renal insufficiency.

APPLICATION FOR VIOLATIONS OF THE FUNCTION OF KIDNEYS

Caution should be used in patients with hepatic and / or renal insufficiency.

APPLICATION FOR CHILDREN

Contraindication: children under 12 years.

SPECIAL INSTRUCTIONS

Do not combine with antitussive.

OVERDOSE

Symptoms: nausea, vomiting, diarrhea, indigestion.

Treatment: gastric lavage is advisable in the first 1-2 hours after taking the drug;
symptomatic therapy.
DRUG INTERACTION

Joint use with antitussive drugs leads to difficulty in getting away from sputum while reducing the cough.

The drug increases the penetration into the bronchial secret of antibiotics.

TERMS OF RELEASE FROM PHARMACY

The drug is approved for use as a means of OTC.

TERMS AND CONDITIONS OF STORAGE

The drug should be stored out of the reach of children, protected from light at a temperature of no higher than 25 В° C.
Shelf life - 2 years.
Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y

Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!